Comparative Pharmacology
Head-to-head clinical analysis: DERMABET versus HC 1.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DERMABET versus HC 1.
DERMABET vs HC #1
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Betamethasone dipropionate is a corticosteroid that diffuses across cell membranes and binds to glucocorticoid receptors, forming a complex that translocates to the nucleus and modulates gene transcription. It induces phospholipase A2 inhibitory proteins (lipocortins), thereby inhibiting the release of arachidonic acid and decreasing the synthesis of prostaglandins and leukotrienes. This results in anti-inflammatory, antipruritic, and vasoconstrictive effects.
Unknown
Apply a thin layer to affected area once or twice daily. Maximum 50 g per week.
Hydrocortisone: 100-200 mg IV as initial dose, then 50-100 mg IV every 6 hours, or 0.18 mg/kg/h IV continuous infusion.
None Documented
None Documented
Terminal elimination half-life: 3-4 hours; prolonged in hepatic impairment
2–4 hours (terminal); prolonged in renal impairment.
Renal (60-70% as unchanged drug and metabolites), biliary/fecal (30-40%)
Renal: 90% as unchanged drug; fecal: 10%.
Category C
Category C
Topical Corticosteroid
Topical Corticosteroid